. Demographic and clinical characteristics of initial patients receiving amyloid-targeting treatments in the United States after regulatory approval. Alzheimers Dement. 2025 Mar;21(3):e70054. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.